198904-53-9

Basic information

• Product Name: 4-(1,3-THIAZOL-2-YL)BENZALDEHYDE
• Synonyms: 4-(1,3-THIAZOL-2-YL)BENZALDEHYDE;4-THIAZOL-2-YL-BENZALDEHYDE;2-(4-Formylphenyl)thiazole-4-carboxylic acid;2-(4-Formylphenyl)thiazole-5-carboxylic acid;4-(5-Nitrothiazol-2-yl)benzaldehyde;4-THIAZOL-2-YL-BENZALDEHYDE, 95+%
• CAS NO: 198904-53-9
• Molecular Formula: C₁₀H₇NOS
• Molecular Weight: 189.23
• Product Categories: Aldehydes;Phenyls & Phenyl-Het;Phenyls & Phenyl-Het
• Mol File: 198904-53-9.mol

Chemical Properties

• Boiling Point: 350.298 °C at 760 mmHg
• Flash Point: 165.655 °C
• Appearance: /
• Density: 1.269 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.645
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-(1,3-THIAZOL-2-YL)BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1,3-THIAZOL-2-YL)BENZALDEHYDE(198904-53-9)
• EPA Substance Registry System: 4-(1,3-THIAZOL-2-YL)BENZALDEHYDE(198904-53-9)

Safety Data

• Hazard Codes: Xi
• Statements: 41
• Safety Statements: 26-39
• Hazardous Substances Data: 198904-53-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-(1,3-THIAZOL-2-YL)BENZALDEHYDE is used as an intermediate in the synthesis of various pharmaceuticals for its potential medicinal properties. It is particularly noted for its antimicrobial and anticancer activities, making it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, 4-(1,3-THIAZOL-2-YL)BENZALDEHYDE is utilized as a precursor in the production of agrochemicals, contributing to the development of effective pest control agents and other agricultural products.
Used in Organic Synthesis:
4-(1,3-THIAZOL-2-YL)BENZALDEHYDE serves as a key building block in organic synthesis, enabling the creation of a wide range of chemical compounds with diverse applications.
Used as a Flavoring Agent in the Food Industry:
Leveraging its strong aromatic and fruity odor, 4-(1,3-THIAZOL-2-YL)BENZALDEHYDE is used as a flavoring agent in the food industry to enhance the taste and aroma of various food products.
Used in Research:
Due to its unique chemical structure and potential applications, 4-(1,3-THIAZOL-2-YL)BENZALDEHYDE is a subject of interest in research, where it is studied for further exploration of its properties and possible uses in various fields.

InChI:InChI=1/C10H7NOS/c12-7-8-1-3-9(4-2-8)10-11-5-6-13-10/h1-7H

Upstream product

• 3034-53-5 2-bromo-1,3-thiazole 
• 24856-58-4 1,1-dimethoxy-1-(4-bromophenyl)methane 
• 87199-17-5 4-formylphenylboronic acid, 
• 3034-52-4 2-chlorothiazole 
• 1122-91-4 4-bromo-benzaldehyde 
• 389630-95-9 (thiazol-2-yl)boronic acid 

Downstream Products

• 198904-55-1 N-1-(tert-butyloxycarbonyl)-N-2-[4-(thiazol-2-yl)benzyl]hydrazine 
• 198904-57-3 1-[4-(thiazol-2-yl)-phenyl]-4(S)-hydroxy-5(S)-2,5-diamino-6-phenyl-2-azahexane 
• 198904-59-5 1-[4-(thiazol-2-yl)-phenyl]-4(S)-hydroxy-2-(tert-butoxycarbonyl)amino-5(S)-amino-6-phenyl-2-azahexane 
• 198904-61-9 1-[4-(thiazol-2-yl)-phenyl]-4(S)-hydroxy-2-amino-5 (S)-N-(N-methoxycarbonyl-(L)-valyl)amino-6-phenyl-2-azahexane 
• 198904-56-2 1-[4-(Thiazol-2-yl)-phenyl]-4(S)-hydroxy-5(S)-2,5-bis[(tert-butoxycarbonyl)amino]-6-phenyl-2-azahexane 
• 198904-58-4 N'-[(2S,3S)-2-Hydroxy-4-phenyl-3-(2,2,2-trifluoro-acetylamino)-butyl]-N'-(4-thiazol-2-yl-benzyl)-hydrazinecarboxylic acid tert-butyl ester 
• 198904-60-8 N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(4-thiazol-2-yl-benzyl)-hydrazinecarboxylic acid tert-butyl ester 
• 198904-02-8 {(S)-1-[N'-[(2S,3S)-2-Hydroxy-3-((S)-2-methoxycarbonylamino-3-methyl-butyrylamino)-4-phenyl-butyl]-N'-(4-thiazol-2-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl}-carbamic acid methyl ester 
• 198904-01-7 CGP 75136 
• 210114-78-6 {3-[(4-thiazol-2-yl-benzylamino)-methyl]-phenoxy}-acetic acid tert-butyl ester 
• 266369-49-7 4-(1,3-Thiazol-2-yl)benzoic acid 
• 1010702-53-0 {(S)-2,2-dimethyl-1-[N'-(4-thiazol-2-ylbenzyl)hydrazinocarbonyl]propyl}carbamic acid methyl ester 
• 454678-91-2 (4-(thiazol-2-yl)phenyl)methanol 
• 1187451-26-8 4-(thiazol-2-yl)benzyl bromide 

Relevant articles and documents

BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER'S DISEASE OR HUNTINGTON'S DISEASE

Benzimidazole compounds of formula (I), shown below, are disclosed. The compounds are potent human glutaminyl cyclase inhibitors. Also disclosed is a pharmaceutical composition containing one of these compounds and a pharmaceutical acceptable carrier, as well as a method of treating Alzheimer's disease or Huntington's disease by administering to a subject in need thereof an effective amount of such a compound.

BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER'S DISEASE OR HUNTINGTON'S DISEASE

Benzimidazole compounds of formula (I), shown below, are disclosed. The compounds are potent human glutaminyl cyclase inhibitors. Also disclosed is a pharmaceutical composition containing one of these compounds and a pharmaceutical acceptable carrier, as well as a method of treating Alzheimer's disease or Huntington's disease by administering to a subject in need thereof an effective amount of such a compound.

COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF

It is related to compounds used as autophagy modulators and a method for preparing and using the same, specifically providing a compound of general formula (I), or pharmaceutically acceptable salts thereof, which is a type of autophagy modulators, particularly mammalian ATG8 homologues modulators.

Discovery of novel “Dual-site” binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors

From our research group, it was noticed that oseltamivir derivatives targeting 150-cavity of neuraminidase enzyme (NA) could significantly increase antiviral activity. Thus, we further enriched the C5–NH2 position of oseltamivir structure to ob

Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity

Poly(adenosine 5′-diphosphate-ribose) polymerase (PARP) inhibitors are a class of anticancer drugs that block the catalytic activity of PARP proteins. Optimization of our lead compound 1 ((Z)-2-benzylidene-3-oxo-2,3-dihydrobenzofuran-7-carboxamide; PARP-1 IC50 = 434 nM) led to a tetrazolyl analogue (51, IC50 = 35 nM) with improved inhibition. Isosteric replacement of the tetrazole ring with a carboxyl group (60, IC50 = 68 nM) gave a promising new lead, which was subsequently optimized to obtain analogues with potent PARP-1 IC50 values (4-197 nM). PARP enzyme profiling revealed that the majority of compounds are selective toward PARP-2 with IC50 values comparable to clinical inhibitors. X-ray crystal structures of the key inhibitors bound to PARP-1 illustrated the mode of interaction with analogue appendages extending toward the PARP-1 adenosine-binding pocket. Compound 81, an isoform-selective PARP-1/-2 (IC50 = 30 nM/2 nM) inhibitor, demonstrated selective cytotoxic effect toward breast cancer gene 1 (BRCA1)-deficient cells compared to isogenic BRCA1-proficient cells.

NOVEL S1P RECEPTOR MODULATING AGENT

An object of the present invention is to provide a compound having a modulating activity at an S1P receptor which is useful for preventing and treating autoimmune diseases, allergic diseases, and the like. According to the present invention, a compound re

Methods of treatment using an EP2 selective receptor agonist

The present invention relates to methods of treating pulmonary hypertension, facilitating joint fusion, facilitating tendon and ligament repair, reducing the occurrence of secondary fracture, treating avascular necrosis, facilitating cartilage repair, facilitating bone healing after limb transplantation, facilitating liver regeneration, facilitating wound healing, reducing the occurrence of gastric ulceration, treating hypertension, facilitating the growth of tooth enamel or finger or toe nails, treating glaucoma, treating ocular hypertension, and repairing damage caused by metastatic bone disease using an EP2 selective receptor agonist.

6-O-acyl ketolide antibacterials

6-O-Acyl ketolide antibacterials of the formula: wherein R1, R2, R3, R4, W, X, X′, Y, and Y′ are as described herein and in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.

Method for treating glaucoma

Methods of using prostaglandin agonists for the reduction of intraocular pressure, and accordingly glaucoma.

Prostaglandin agonists and their use to treat bone disorders

This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.